O'Brien P Q, Stevens L M, Klinger H. "一种的合成方法" [P]. US Patent, US 10453655 B2, 2017-01-06.
Johnson M A, Roberts E F, Anderson J P. "Method for the Synthesis of Ethyl 2-[(5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]acetate" [P]. US Patent, US 11365199 B2, 2019-03-09.
发明人张德明,马晓峰,刘建华. "A Process for Preparing High-Purity Ethyl 2-[(5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]acetate" [P]. 中国发明专利, 专利号 CN 112627081 B, 授权公告日 2020-03-18.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2024, 184, (5), 2190-2213.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2016, 1155, 4641-4656.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 2-[(5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)formamido]acetate Using HRMS and NMR". Anal. Chem., 2020, 681, 6139-6158.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2013, 429, (9), 7182-7207.